<code id='A85DA046EA'></code><style id='A85DA046EA'></style>
    • <acronym id='A85DA046EA'></acronym>
      <center id='A85DA046EA'><center id='A85DA046EA'><tfoot id='A85DA046EA'></tfoot></center><abbr id='A85DA046EA'><dir id='A85DA046EA'><tfoot id='A85DA046EA'></tfoot><noframes id='A85DA046EA'>

    • <optgroup id='A85DA046EA'><strike id='A85DA046EA'><sup id='A85DA046EA'></sup></strike><code id='A85DA046EA'></code></optgroup>
        1. <b id='A85DA046EA'><label id='A85DA046EA'><select id='A85DA046EA'><dt id='A85DA046EA'><span id='A85DA046EA'></span></dt></select></label></b><u id='A85DA046EA'></u>
          <i id='A85DA046EA'><strike id='A85DA046EA'><tt id='A85DA046EA'><pre id='A85DA046EA'></pre></tt></strike></i>

          knowledge

          knowledge

          author:knowledge    Page View:21
          Two business miniatures talk to each other on coin stacks that are sandwiched by a syringe and a stethoscope — coverage from STAT
          Adobe

          For all the flak they get, the country’s four biggest pharmacy benefit managers reported a surprisingly tame average profit margin in the first three quarters of 2023: 4.5%, less than a third of their drugmaker peers.

          But don’t take their numbers as gospel, experts warned.

          advertisement

          “It’s really easy to move money around inside the books of a vertically integrated organization,” said Karen Van Nuys, a senior fellow at the USC Schaeffer Center for Health Policy and Economics. “If one segment of your vertically integrated organization is not publishing any financial data, it’s a good place to hide stuff.”

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          focus

          Supreme Court strikes down use of affirmative action
          Supreme Court strikes down use of affirmative action

          ActivistsdemonstratedastheSupremeCourtheardoralargumentsonapairofaffirmativeactioncasesinOctober2022

          read more
          He's a Nobel laureate. Critics say he was misleading on Covid
          He's a Nobel laureate. Critics say he was misleading on Covid

          Photoillustration:AlexHogan/STAT;Sourcephoto:AFPviaGettyOnedaylastAugust,astheystruggledtofigureoutw

          read more
          How one medical school became remarkably diverse
          How one medical school became remarkably diverse

          ThefirstclassattheUniversityofCalifornia,Davismedicalschool,in1972,waspredominantlywhiteandmale.Chri

          read more

          Merck drug for rare lung condition set for approval in U.S.

          AdobeTheFoodandDrugAdministrationisexpectedtoapproveMerck’sdrugtotreatararelungdisordercalledpulmona